Recommendation of Pfizer vaccine booster dose for some under review

Oregon is ready to make booster shots available to people who are eligible to receive one, if the Western States Scientific Safety Review Workgroup approves a federal recommendation to make booster shots of the Pfizer vaccine available to seniors and people in high-risk categories. While Oregon currently has an adequate supply of Pfizer vaccines, provider […]

El OHA publica una declaración sobre la recomendación de dosis de refuerzo

Hoy, los funcionarios de la Administración de Alimentos y Medicamentos (FDA) se reunieron con expertos médicos para discutir si recomendar que las personas que previamente han sido vacunadas por completo con la vacuna contra el COVID-19 de Pfizer, reciban una inyección de refuerzo para ayudar a mantener la efectividad de sus vacunas durante tiempo. En […]

OHA releases statement on booster dose recommendation

Today, officials from the Food and Drug Administration (FDA) convened medical experts to discuss whether to recommend that people who’ve previously been fully vaccinated with the Pfizer COVID-19 vaccine should receive a booster shot to help maintain the effectiveness of their vaccinations over time. At today’s hearing, the committee recommended that people age 65 and […]

La FDA aprueba la vacuna Pfizer contra el COVID-19

Hoy, la Administración de Drogas y Alimentos de los Estados Unidos (FDA) otorgó la aprobación total a la vacuna Pfizer-BioNTech mRNA contra el COVID-19, que se comercializará bajo el nombre de “Comirnaty”. Bajo la aprobación de la FDA, Comirnaty estará disponible para todas las personas mayores de 16 años para prevenir la enfermedad por el […]

FDA, CDC and Western States recommend additional vaccine dose for immunocompromised individuals

The U.S. Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup have all recommended an additional dose of mRNA COVID-19 vaccine be administered to people with moderately to severely compromised immune systems. On Aug. 12, the U.S. Food and Drug Administration (FDA) adjusted the existing […]

Actualizaciones sobre la variante Delta

Hemos escuchado en las noticias y en medios sociales sobre la variante del COVID-19 llamada B.1.617.2 o Delta. Muchos se preguntan, qué es, dónde se ha propagado y si deberíamos preocuparnos. Esto es lo que necesita saber. Definiendo a la variante Delta La variante Delta está clasificada por los Centros para el Control y la […]

Small risk of Guillain-Barré Syndrome (GBS) associated with Johnson & Johnson vaccine

Today, the Centers for Disease Control and Prevention (CDC) reported that reports to the U.S. Vaccine Adverse Events Reporting System (VAERS) indicate a small risk of Guillain-Barré Syndrome (GBS) following receipt of the Johnson & Johnson (J&J) COVID-19 vaccine. About 100 preliminary reports of GBS have been filed with VAERS after the administration of 12.8 million doses of the J&J vaccine. The cases were largely […]

Myocarditis and pericarditis: Weighing the risks of these rare side effects

You may have heard about the risk of myocarditis and pericarditis after some COVID-19 vaccines. Understanding that the risk is extremely small and knowing what to watch out for after vaccination may help you decide what’s the best choice for you or your child. Myocarditis is an inflammation of the heart muscle. Pericarditis is an […]